∗Department of Otolaryngology–Head and Neck Surgery, Vanderbilt University Medical Center

†Department of Hearing and Speech Science, Vanderbilt Bill Wilkerson Center, Vanderbilt University Medical Center, Nashville, Tennessee

Address correspondence and reprint requests to Ankita Patro, M.D., M.S., Department of Otolaryngology–Head and Neck Surgery, Vanderbilt University Medical Center, 7209 Medical Center East—South Tower, 1215 21st Avenue South, Nashville, TN 37232-8605; E-mail: [email protected]

Sources of support and disclosure of funding: The work presented here was supported by the National Institutes of Health (NIH/NIDCD R01 DC13117 and UL1 TR000445, PI: René Gifford, PhD).

K.O.T. has served as an advisory board member for GlaxoSmithKline. D.S.H. is a consultant for Advanced Bionics, Cochlear Americas, MED-EL GmbH, Stryker, Synthes, Grace Medical, and Oticon. R.G. is a consultant for Advanced Bionics, Akouos, and Cochlear Americas; is on the clinical advisory board for Frequency Therapeutics; and is on the Board of Directors for the American Auditory Society. The other authors disclose no conflicts of interest.

Institutional review board: Vanderbilt University IRB Approval No. 211355.